Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rubino

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
The European Journal of Neuroscience|November 1, 1995
Morphine withdrawal syndrome and G protein expression: a study of the time course in the rat central nervous systemT Rubino, M Parenti, G Patrini, et al.
Synapse (New York, N.Y.)|December 1, 1999
In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatmentsT Rubino, D Viganò, E Zagato, et al.
Veterinary Immunology and Immunopathology|October 6, 2001
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophagesW Ponti, T Rubino, M Bardotti, et al.
Journal of Neurochemistry|November 18, 2000
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant ratsT Rubino, D Viganò, B Costa, et al.
Neuropharmacology|November 5, 2016
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviorsA Simonnet, E Zamberletti, M Cador, et al.
Neuroreport|November 14, 1997
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentT Rubino, L Tizzoni, D Viganò, et al.
Life Sciences|June 2, 2000
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndromeT Rubino, P Massi, D Viganò, et al.
European Journal of Pharmacology|July 21, 1992
Influence of omega-conotoxin on morphine analgesia and withdrawal syndrome in ratsL Basilico, D Parolaro, T Rubino, et al.
Brain Research. Molecular Brain Research|March 1, 1997
Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous systemT Rubino, G Patrini, M Parenti, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1997
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic studyP Massi, G Patrini, T Rubino, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
The European Journal of Neuroscience|November 1, 1995
Morphine withdrawal syndrome and G protein expression: a study of the time course in the rat central nervous systemT Rubino, M Parenti, G Patrini, et al.
Synapse (New York, N.Y.)|December 1, 1999
In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatmentsT Rubino, D Viganò, E Zagato, et al.
Veterinary Immunology and Immunopathology|October 6, 2001
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophagesW Ponti, T Rubino, M Bardotti, et al.
Journal of Neurochemistry|November 18, 2000
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant ratsT Rubino, D Viganò, B Costa, et al.
Neuropharmacology|November 5, 2016
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviorsA Simonnet, E Zamberletti, M Cador, et al.
Neuroreport|November 14, 1997
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentT Rubino, L Tizzoni, D Viganò, et al.
Life Sciences|June 2, 2000
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndromeT Rubino, P Massi, D Viganò, et al.
European Journal of Pharmacology|July 21, 1992
Influence of omega-conotoxin on morphine analgesia and withdrawal syndrome in ratsL Basilico, D Parolaro, T Rubino, et al.
Brain Research. Molecular Brain Research|March 1, 1997
Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous systemT Rubino, G Patrini, M Parenti, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1997
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic studyP Massi, G Patrini, T Rubino, et al.
Pageof 8